AtriCure, Inc. (NASDAQ:ATRC) - AtriCure: Q1 Earnings Insight

AtriCure, Inc. (NASDAQ:ATRC) - AtriCure: Q1 Earnings Insights


52-week low: $34.04
Company Description
AtriCure Inc an atrial fibrillation solutions company that provides products, professional education, and support for clinical science to reduce the economic and social burden of atrial fibrillation. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States.
 
Related Articles (ATRC)

Related Keywords

United States , , Atricure Inc , Company Description , Secure Inc , Soft Tissue Dissection , ஒன்றுபட்டது மாநிலங்களில் , நிறுவனம் விளக்கம் , குணப்படுத்த இன்க் , மென்மையான திசு பிரித்தல் ,

© 2025 Vimarsana